Status:
TERMINATED
Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM)
Lead Sponsor:
Institut de cancérologie Strasbourg Europe
Collaborating Sponsors:
Hôpitaux Universitaires de Strasbourg
Conditions:
Squamous Cell Carcinoma of Head and Neck
Oropharyngeal Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a monocentric, non-randomized, prospective, in silico feasibility study conducted by Strasbourg Europe Cancerology Institute. The purpose of this study is to evaluate the optimisation of poten...
Detailed Description
35 patients will be included in this study and will benefit from a dental consultation for dental rehabilitation plan elaboration and radiological guide confection. Two dosimetric computer-tomography ...
Eligibility Criteria
Inclusion
- Patients must be ≥ 18 years old
- Performance Status 0 to 2
- Histologically-confirmed diagnosis of : infiltrating squamous cell carcinoma of the oral cavity or oropharynx
- Indication for an exclusive radiotherapy or post-surgery radiotherapy, with or without chemotherapy
- Indication for a radiotherapy of lymph node areas
- Partial or complete toothlessness requiring rehabilitation
- Signed informed consent from the patient
Exclusion
- History of head and neck radiotherapy
- Partial mandibulectomy
- Retarded wound healing or trismus impairing radiological guide preparation
- Patient refusing the study
- Pregnant women
Key Trial Info
Start Date :
May 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 17 2025
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04801472
Start Date
May 7 2021
End Date
June 17 2025
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de cancérologie Strasbourg Europe
Strasbourg, France, 67033